ERBB2 and adenocarcinoma: In our patient cohort, we found that HER2 alteration was more frequently observed in adenocarcinoma than other histological types, whereas there was no significant association of HER2 amplification or mutation with gender, age and smoking status in our research, and another study supported our views.36